1
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jeswani S, Nuño M, Folkerts V and Bigg J:
Comparison of survival between cerebellar and supratentorial
glioblastoma patients: surveillance, epidemiology, and end results
(SEER) analysis. Neurosurgery. 73:240–246. 2013. View Article : Google Scholar
|
3
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar
|
4
|
Noushmehr H, Weisenberger DJ, Diefes K, et
al: Identification of a CpG island methylator phenotype that
defines a distinct subgroup of glioma. Cancer Cell. 17:510–522.
2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Martinez R, Martin-Subero JI, Rohde V, et
al: A microarray-based DNA methylation study of glioblastoma
multiforme. Epigenetics. 4:255–264. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Murphy EV, Zhang Y, Zhu W, et al: The
human glioma pathogenesis-related protein is structurally related
to plant pathogenesis-related proteins and its gene is expressed
specifically in brain tumors. Gene. 159:131–135. 1995. View Article : Google Scholar
|
7
|
Rich T, Chen P, Furman F, et al: RTVP-1, a
novel human gene with sequence similarity to genes of diverse
species, is expressed in tumor cell lines of glial but not neuronal
origin. Gene. 180:125–130. 1996. View Article : Google Scholar
|
8
|
Rosenzweig T, Ziv-Av A, Xiang C, et al:
Related to testes-specific, vespid, and pathogenesis protein-1
(RTVP-1) is overexpressed in gliomas and regulates the growth,
survival, and invasion of glioma cells. Cancer Res. 66:4139–4148.
2006. View Article : Google Scholar
|
9
|
Xiang C, Sarid R, Cazacu S, et al: Cloning
and characterization of human RTVP-1b, a novel splice variant of
RTVP-1 in glioma cells. Biochem Biophys Res Commun. 362:612–618.
2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ren C, Li L, Yang G, et al: RTVP-1, a
tumor suppressor inactivated by methylation in prostate cancer.
Cancer Res. 64:969–976. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Liang T, Tan T, Xiao Y, et al: Methylation
and expression of glioma pathogenesis-related protein 1 gene in
acute myeloid leukemia. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
34:388–394. 2009.(In Chinese).
|
12
|
Chilukamarri L, Hancock AL, Malik S, et
al: Hypomethylation and aberrant expression of the glioma
pathogenesis-related 1 gene in Wilms tumors. Neoplasia. 9:970–978.
2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Awasthi A, Woolley AG, Lecomte FJ, et al:
Variable expression of GLIPR1 correlates with invasive potential in
melanoma cells. Front Oncol. 3:2252013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ehrich M, Nelson MR, Stanssens P, et al:
Quantitative high-throughput analysis of DNA methylation patterns
by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci
USA. 102:15785–15790. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Bier A, Giladi N, Kronfeld N, et al:
MicroRNA-137 is downregulated in glioblastoma and inhibits the
stemness of glioma stem cells by targeting RTVP-1. Oncotarget.
4:665–676. 2013.PubMed/NCBI
|
16
|
Ren C, Li L, Goltsov AA, et al: mRTVP-1, a
novel p53 target gene with proapoptotic activities. Mol Cell Biol.
22:3345–3357. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Li L, Fattah EA, Cao G, et al: Glioma
pathogenesis-related protein 1 exerts tumor suppressor activities
through proapoptotic reactive oxygen species-c-Jun-NH2
kinase signaling. Cancer Res. 68:434–443. 2008. View Article : Google Scholar
|
18
|
Thompson TC: Glioma pathogenesis-related
protein 1: tumor-suppressor activities and therapeutic potential.
Yonsei Med J. 51:479–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dong SM, Pang JC, Poon WS, et al:
Concurrent hypermethylation of multiple genes is associated with
grade of oligodendroglial tumors. J Neuropathol Exp Neurol.
60:808–816. 2001.PubMed/NCBI
|
20
|
Wolter M, Reifenberger J, Blaschke B, et
al: Oligodendroglial tumors frequently demonstrate hypermethylation
of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b)
tumor suppressor genes. J Neuropathol Exp Neurol. 60:1170–1180.
2001.
|
21
|
Noushmehr H, Weisenberger DJ, Diefes K, et
al: Identification of a CpG island methylator phenotype that
defines a distinct subgroup of glioma. Cancer Cell. 17:510–522.
2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Everhard S, Tost J, El Abdalaoui H, et al:
Identification of regions correlating MGMT promoter methylation and
gene expression in glioblastomas. Neuro Oncol. 11:348–356. 2009.
View Article : Google Scholar : PubMed/NCBI
|